Latest News for: ide

Edit

Galaxy Therapeutics Completes Enrollment in Pivotal SEAL IT IDE Trial

PR Newswire 23 Dec 2025
MILPITAS, Calif., Dec ... IDE trial evaluating the SEAL device for brain aneurysms ... Sam Zaidat, President and CEO of Galaxy Therapeutics ... IDE trials to include a ruptured aneurysm cohort, a critical and underrepresented population in device studies ... Logo. ... .
Edit

Films of the year 2025: Wendy Ide

Screen Daily 22 Dec 2025
Wendy Ide is ’s senior international critic, and chief film critic for. Best film. 1. Sirât. Dir. Oliver Laxe ... A film that genuinely shocked the Cannes audience. 2. Sorry, Baby. Dir. Eva Victor. Droll, intimate, profound and painfully honest ... .
Edit

UN declares famine over in Gaza, says 'situation remains critical'

Vincennes Sun-Commercial 20 Dec 2025
A famine declared in Gaza in August is now over thanks to improved access for humanitarian aid, the United Nations said on Friday, but warned the food situation in the Palestinian territory remained dire ... .
Edit

Pope replaces New York's pro-Trump Cardinal with pro-migrant Chicagoan

The Moore County News Press 19 Dec 2025
The newly named pro-migrant archbishop of New York called himself an "unworthy servant" during his first Mass in the city after Pope Leo XIV named his fellow Chicago native to replace a conservative cardinal Thursday ....
Edit

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study ...

Enid News & Eagle 18 Dec 2025
HAYWARD, Calif.--(BUSINESS WIRE)--Dec 18, 2025-- ... .
Edit

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation (Form 8-K) (Pulse Biosciences Inc)

Public Technologies 18 Dec 2025
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation ... We look forward to the results of this IDE as the clinical data continue to evolve.".
Edit

Pope replaces New York's Cardinal Dolan with pro-migrant bishop

Chronicle Tribune 18 Dec 2025
Pope Leo XIV has accepted the resignation of New York's conservative Archbishop Timothy Dolan and named a little-known, pro-migrant bishop from his native Chicago to replace him, the Vatican said Thursday ....
Edit

'Immense' collection of dinosaur footprints found in Italy

Princeton Daily Clarion 17 Dec 2025
Hundreds of metres of dinosaur tracks with toes and claws have been found in the Italian Alps in a region that will host the 2026 Winter Olympics, authorities said Tuesday ... .
Edit

Attackers on Sydney Hanukkah celebration IDed as father and son Sajid and Naveed Akram

Cleveland Jewish News 15 Dec 2025
Australian authorities have identified the two gunmen who unleashed a deadly shooting attack on a Jewish event at Sydney’s Bondi Beach as a father and son who are Pakistani nationals ... .
Edit

AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy

PR Newswire 12 Dec 2025
Dr ... AB-10-8002 is a multicenter, randomized, open-label Phase II study evaluating the safety and efficacy of 24-week AHB-137 monotherapy in HBeAg-negative chronic hepatitis B patients who are receiving stable nucleos(t)ide analogue (NA) therapy ... 21% ... .
Edit

JetBrains discontinues Fleet IDE

InfoWorld 11 Dec 2025
JetBrains is discontinuing its Fleet IDE, stating that it could not justify maintaining two general-purpose IDEs. The JetBrains flagship IDE is IntelliJ, and Fleet did not succeed as a standalone product, the company said.
Edit

Airiver Medical Secures IDE Approval from the FDA for Pivotal Clinical Study of the Airiver ...

Winona Daily News 10 Dec 2025
The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the nasal passageways with drug delivery designed to maintain symptom relief ... .
  • 1

Article Search

tools
×
×
×
×